State Key Laboratory of Pharmaceutical Biotechnology, Jiangsu Engineering Research Center for microRNA Biology and Biotechnology, NJU Advanced Institute for Life Sciences (NAILS), School of Life Sciences, Nanjing University, Nanjing, 210093, China.
The Drug Laboratory of Mongolian Medicine, and Pharmacy Institute, Inner Mongolia International Mongolian Hospital, Hohhot, 010065, China.
Sci China Life Sci. 2019 Mar;62(3):349-356. doi: 10.1007/s11427-017-9277-9. Epub 2018 Mar 27.
Ophiocordyceps sinensis is well known as a traditional Chinese medicine and has widely been used for over 2,000 years to stimulate immune system, decrease blood pressure and to inhibit tumor growth. While miRNAs are increasingly recognized for their roles in post-transcriptional regulation of gene expression in animals and plants, miRNAs in fungi were less studied until the discovery of microRNA-like RNA (milRNA). High-throughput sequencing and bioinformatics approaches were used to identify conserved and novel milRNAs in O. sinensis. 40 conserved milRNAs were identified, while 23 pre-miRNA candidates encoding 31 novel milRNAs were predicted. Furthermore, the potential target genes of milRNAs in human were predicted and gene ontology analysis was applied to these genes. Enrichment analysis of GO-represented biological process showed that target genes of both conserved and novel milRNAs are involved in development, metabolic and immune processes, indicating the potential roles of milRNAs of O. sinensis in pharmacological effects as health food and traditional Chinese medicine. This study is the first report on genome-wide analysis of milRNAs in O. sinensis and it provides a useful resource to further study the potential roles of milRNAs as active components of O. sinensis in health food or traditional Chinese medicine.
冬虫夏草作为一种传统中药,在提高免疫系统功能、降低血压和抑制肿瘤生长等方面已有两千多年的应用历史。miRNAs 在动植物中作为基因表达的转录后调控因子的作用已得到广泛认可,而真菌中的 miRNAs 直到 microRNA-like RNA (milRNA) 的发现才开始得到研究。本研究采用高通量测序和生物信息学方法鉴定了冬虫夏草中的保守和新型 milRNAs。鉴定到 40 个保守的 milRNAs,预测到 23 个前体 miRNA 候选基因,可编码 31 个新型 milRNAs。进一步预测了 milRNAs 的人源潜在靶基因,并对这些基因进行了基因本体论分析。GO 代表的生物过程富集分析表明,保守和新型 milRNAs 的靶基因都参与了发育、代谢和免疫过程,表明 milRNAs 可能在冬虫夏草作为保健品和传统中药的药理学作用中发挥重要作用。本研究是首次对冬虫夏草中 milRNAs 的全基因组分析,为进一步研究 milRNAs 作为冬虫夏草活性成分在保健品或传统中药中的潜在作用提供了有用资源。